Mark Karides, MD practices hematology/oncology in Chicago, IL. Mark is also listed as specializing in hematology & oncology. Medicare claims data shows Mark provided 161,748 services to 1,501 patients.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Dr. Karides is a hematology/oncology in Chicago, IL. This is the primary taxonomy recorded against the NPI in the federal registry, listed there as “HEMATOLOGY/ONCOLOGY”.
NPI registry
Dr. Karides is listed at 7447 W TALCOTT AVE SUITE ONE, Chicago, IL 60631. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (773) 774-0042. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. Karides's National Provider Identifier is 1932206307. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Karides attended Other, graduating in 1988. This comes from the CMS National Downloadable File.
CMS public data
Dr. Karides has 38 years experience. Calculated from a graduation year of 1988, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Karides provides treatments such as administration of chemotherapy into vein, 1 hour or less and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Karides. If this is you, claiming it is free.
Guide.md
Source: NPPES NPI Registry
7447 W TALCOTT AVE SUITE ONE
Chicago, IL 60631
161,748 services · 1,501 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
559 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
548 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
433 |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
264 |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
181 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
170 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
22,300 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
20,420 |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
19,800 |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
15,450 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Verify your identity to control how patients — and AI assistants — describe you.
Claim this profileConnections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Same specialty, same city.
Other providers in the same specialty who trained at the same institution.
Providers who graduated from the same medical school in the same year.
Providers in IL who bill this service to Medicare most often.
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.